Latest AI and machine learning research in skin cancer for healthcare professionals.
Cancer vaccines are an attractive immunotherapeutic approach, and numerous clinical trials are ongoing. However, most candidates have not achieved statistically significant improvements in patient survival. To address these limitations, nanotechnology-enabled cancer nanovaccine platforms have attracted increasing attention. Relative to conventional vaccine formats, cancer nanovaccines can improve ...
The ability to predict T-cell receptor (TCR) specificity from sequences could transform immunotherapy, vaccine development, and our understanding of i...
Although diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease, existing prognostic tools, including the revised International Prognostic I...
Uveal melanoma is the most frequent primary intraocular malignancy in adults and is characterized by an aggressive clinical course, high propensity fo...
Gastric cancer (GC) shows strong biological heterogeneity and frequent disruption of inflammatory and metabolic programs, which affect tumor progressi...
OBJECTIVE: To develop and evaluate an automated CT liver lesion-tracking algorithm that matches lesions over time, detects new metastases, and reports...
PURPOSE: Muscle-invasive bladder cancer (MIBC) remains biologically heterogeneous, and clinicopathological variables do not fully capture epithelial-s...
Non-small cell lung cancer (NSCLC) is the most common cancer-related cause of death among all countries globally, mostly because of late diagnosis, he...
BACKGROUND: Head and neck squamous cell carcinomas (HNSCCs) cause considerable morbidity and mortality. Multimodal treatment strategies can cause sign...
Cancer is among the major causes of morbidity and mortality worldwide, and current treatment methods are limited by various drawbacks such as drug res...
Deep learning holds significant promise for improving clear cell renal cell carcinoma (ccRCC) diagnosis and treatment. However, studies concerning tum...
Head and neck squamous cell carcinoma (HNSCC) is a highly heterogeneous malignancy with poor prognosis, accompanied by metabolic reprogramming and tum...
Microvascular invasion (MVI) is a key prognostic factor in hepatocellular carcinoma but is currently only detectable after surgery. Here, we develop M...
BACKGROUND: Cancer is a major threat to human health, and cancer immunotherapy is considered the most promising treatment option. It offers high effec...
BACKGROUND: Human immunodeficiency virus (HIV) is a lentivirus belonging to the retrovirus subclass. HIV specifically targets and infects human CD4 + ...
The synergistic integration of chemotherapy and immunotherapy represents the most promising strategy for enhancing therapeutic efficacy in cancer trea...
Severe asthma remains a major unmet clinical challenge due to its marked immunological heterogeneity and the limited efficacy of current therapies in ...
Lung Squamous Cell Carcinoma (LUSC), a common subtype of non-small cell lung cancer, primarily occurs in elderly individuals and is closely linked to ...
Analysis of multimodal and multidimensional data capturing dynamic interactions between diverse cell populations is a current challenge in bioimaging,...